{"id":"W2919740967","doi":"10.1177/1759720x19831151","title":"Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Musculoskeletal Disease","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; McMaster University; Université du Québec à Rimouski; University of Toronto; Centre Hospitalier de l’Université de Montréal; Wilfrid Laurier University; Université Laval","funders":"Novartis Pharma; UCB; UCB Pharma; Pfizer; Eli Lilly and Company","keywords":"Medicine; Certolizumab pegol; Rheumatoid arthritis; Observational study; Adverse effect; Internal medicine; Physical therapy; Incidence (geometry); Bristol-Myers; Minimal clinically important difference; Randomized controlled trial; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580155,0.0007774545,0.001016511,0.001042108,0.002117947,0.001408869,0.001544568,0.001026738,0.001578753],"category_scores_gemma":[0.01284327,0.0005245226,0.001539239,0.003931383,0.001048623,0.0006788924,0.00110794,0.001124332,0.0002935651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02838292,"about_ca_system_score_gemma":0.04129623,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9539959,"about_ca_topic_score_gemma":0.9553355,"domain_scores_codex":[0.9939204,0.0009926684,0.0004291236,0.0006718441,0.002967264,0.001018652],"domain_scores_gemma":[0.9804693,0.001549886,0.006597425,0.0006675674,0.00793081,0.002784906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002335688,0.0004933967,0.9836173,0.0002225877,0.0004675926,0.00006950249,0.0007845678,0.0002282775,0.0001488991,0.00005534161,0.001868031,0.009708819],"study_design_scores_gemma":[0.0003282565,0.0005813386,0.9971413,0.00005040203,0.0001577883,0.00004699617,0.0003575285,0.0003091317,0.00004926842,0.00001067253,0.00093859,0.00002869538],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891094,0.001686216,0.0001149622,0.0004140876,0.00002293771,0.0003256382,0.006642031,0.00001647324,0.001668208],"genre_scores_gemma":[0.9928759,0.0009615965,0.0004456785,0.0003755008,0.00003533347,0.0001352893,0.004645117,0.000006065517,0.0005195324],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04600412,"threshold_uncertainty_score":0.2059335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01027250520756002,"score_gpt":0.3003478798743314,"score_spread":0.2900753746667714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}